Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Marc ArbynUnit of Cancer Epidemiology, Scientific Institute of Public Health, Brussels, Belgium. [email protected]Guglielmo RoncoUnit of Cancer Epidemiology, Centro per la prevenzione Oncologica, Turin, ItalyAhti AnttilaMass Screening Registry, Finnish Cancer Registry, Helsinki, FinlandChris J.L.M. MeijerDepartment of Pathology, VU University Medical Centre, Amsterdam, The NetherlandsMario PoljakInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, SloveniaGina OgilvieDivision of STI/HIV Prevention and Control, BC Centre for Disease Control, Vancouver, CanadaGeorge KoliopoulosDepartment of Obstetrics and Gynecology, University Hospital of Ioannina, Ioannina, GreecePontus NauclérDepartment of Microbiology, Tumor & Cell Biology, Karolinska University Hospital, Stockholm, SwedenRengaswamy SankaranarayananScreening Group, International Agency for Research on Cancer, Lyon, FranceJulian PetoLondon School of Hygiene and Tropical Medicine, London, UK
2012en
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba